340 likes | 708 Views
Multivessel PCI on top of culprit lesion revascularization?. No way!. Major issues. How do you define complete revascularization in multivessel disease (MVD)? What is the risk-benefit balance of culprit vs multivessel PCI in stable MVD?
E N D
Multivessel PCI on top of culprit lesion revascularization? No way!
Major issues • How do you define complete revascularization in multivessel disease (MVD)? • What is the risk-benefit balance of culprit vs multivessel PCI in stable MVD? • What is the risk-benefit balance of culprit vs multivessel PCI in acute MVD?
Major issues • How do you define complete revascularization in multivessel disease (MVD)? • What is the risk-benefit balance of culprit vs multivessel PCI in stable MVD? • What is the risk-benefit balance of culprit vs multivessel PCI in acute MVD?
Defining revascularization • Anatomically complete: PCI of every occluded or stenotic epicardial vessel • Functionally complete: PCI of every occluded or stenotic epicardial vessel of adequate size and supplying a zone of viable myocardium • Incomplete (culprit only): PCI of occluded or stenotic epicardial vessel identified by clinical judgement as responsible for signs/symptoms of ischemia • Incomplete (truly): everything else
Hazards of multivessel stenting Orlic et al, JACC 2004
Major issues • How do you define complete revascularization in multivessel disease (MVD)? • What is the risk-benefit balance of culprit vs multivessel PCI in stable MVD? • What is the risk-benefit balance of culprit vs multivessel PCI in acute MVD?
PCI based only on oculostenotic reflex is not justified in stable MVD
Even symptomatic benefits are only marginal in unselected patients Boden et al, NEJM 2007
Major issues • How do you define complete revascularization in multivessel disease (MVD)? • What is the risk-benefit balance of culprit vs multivessel PCI in stable MVD? • What is the risk-benefit balance of culprit vs multivessel PCI in acute MVD?
PCI based only on oculostenotic reflex is also not justified in acute MVD Hirsch et al, Lancet 2007
Multivessel PCI in acute MVD: incremental benefits or costs? Brener et al, Am J Cardiol 2002
What about complete PCI in STEMI? Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study.Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P, Emanuela P, Stefano DS,Angelo R, Stefania C, Anna F, Carmelo C, Antonio C, Monzini N, Bonardi MA. Int J Cardiovasc Intervent. 2004;6(3-4):128-33.
53 vs 69 minutes, p<0.05 22,330€ vs 20,382€, p=NS 35% vs 17% p=NS 0 vs 4%, p=NS Di Mario et al, Int J Cardiovasc Intervent 2004
Take home messages • Current data disCOURAGE from extensive multivessel PCI based only on angiographic assessment in stable MVD • No definite benefits have been shown from multivessel PCI in patients with acute CAD and MVD (either STEMI or NSTEACS) • According to evidence available to date, PCI of non-culprit vessels can thus be recommended only is selected cases
For further slides on these topics please feel free to visit the metcardio.org website:http://www.metcardio.org/slides.html